Skip to content
FDA drug shortage status

Is Lamivudine Injection (Epivir) in shortage?

Lamivudine Injection is listed by FDA as being discontinued by at least one maker (updated Nov 16, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Epivir, Injection, 10 mg/1 mL (NDC 49702-205-48)
    ViiV Healthcare CompanyBeing discontinuedUpdated Nov 16, 2026Discontinued Nov 16, 2026

    The anticipated date that ViiV will cease distribution of the product is approximately May 14, 2027.

    Maker contact: 877-844-8872

FDA recalls of Lamivudine

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Lamivudine Injection:

Other forms on FDA’s list

Lamivudine Injection shortage questions

Is Lamivudine Injection (Epivir) in shortage?

Lamivudine Injection is listed by FDA as being discontinued by at least one maker (updated Nov 16, 2026).

What should I do if I can’t get Lamivudine Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.